chart 7 is very informative.
you can see the curves were uniform untill June when every thing went haywire.
starting june new strains were added the ones of 2 days incubation period and 21 days incubation period.
!
where id they come from new epidemics? with new strains of Ebola.
so in June the alarm should had started and the isolation of three countries started to prevent world wide spread.
I am afraid now it is too late with the long time incubation period 21 days (may be there are ones with 40 days incubation period , who knows.
I went digging for medical research, and found that there are so many suppressed research.
a study by Zairian doctors in 1999 confirm blood donation was 80% life saving compared with 80% death with out blood donation from survivor. this
study followed by so many studies I could not count refering to the blood donation (antibodies from survivors) helping not only in humans but in many
animals even between species.
another study by xavier university clearly states ebola is bioweapon. and that antibodies are the best treatment.
but always some people criticizing the finding as not confirmed by scientific methodology??
kind of wasting time.
to advance medical drugs and the Takimura is actually a kind of DDT )anti RNA) just like dr Ron Paul said (was labled stupid by journalists, same
journalists who did not manage to find the suppressed studies (by media of course)
ebola blood
jid.oxfordjournals.org... 1999
Treatment of Ebola Hemorrhagic Fever with Blood Transfusions from Convalescent Patients
-------
jama.jamanetwork.com...
Hemorrhagic Fever Viruses as Biological Weapons
---------
cmr.asm.org...
Passive Immunity in Prevention and Treatment of Infectious Diseases
---------------------
The potential of antibody-mediated immunity in the defence against biological weapons.
www.ncbi.nlm.nih.gov...
Antibody-mediated immunity (AMI) has been used for the treatment and prevention of infectious diseases for > 100 years, and has a remarkable record of
safety, efficacy and versatility. AMI can be used for defence against a wide variety of biological weapons, and passive antibody (Ab) therapy has the
potential to provide immediate immunity to susceptible individuals
----------------
Enhanced Immunological Sensitization of Mice by the Simultaneous Injection of Antigen and Specific Antiserum
I. Effect of Varying the Amount of Antigen Used Relative to the Antiserum1
www.jimmunol.org...
www.ncbi.nlm.nih.gov...
----------------
A Proposed Mechanism for Natural Immunity to Enterobacterial Pathogens
Department of Experimental Chemotherapy, Institut Pasteur, Paris, France
www.jimmunol.org...
1968!
Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a Mutant Escherichia coli
www.nejm.org...
1
www.jimmunol.org...
www.ncbi.nlm.nih.gov...
----------------
a study shows that antibodies for a germ can help against a different Germ!!
A Proposed Mechanism for Natural Immunity to Enterobacterial Pathogens
Department of Experimental Chemotherapy, Institut Pasteur, Paris, France
www.jimmunol.org...
1968!
Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a Mutant Escherichia coli
www.nejm.org...
---------------------
Passive transfer of antibodies protects immunocompetent and immunodeficient mice against lethal Ebola virus infection without complete inhibition of
viral replication
www.ncbi.nlm.nih.gov...
------------------------------
www.ncbi.nlm.nih.gov...
Passive antibody administration (immediate immunity) as a specific defense against biological weapons.
scholar.google.com...:en-us:IE-ContextMenu&oe=&gws_rd=ssl&um=1&ie=UTF-8&lr=&cites=11246835995819184099
Viral Hemorrhagic Fevers:
Many viral agents are known to cause hemorrhagic fevers,
including Ebola, Marburg, and Junin viruses. Passive antibody
has been used for the treatment of Ebola (57), Argentine (58),
and Lassa (59) hemorrhagic fevers, with encouraging results
Furthermore, considerable evidence from animal studies indi-
cates that passive antibody administration prevents or amelio-
rates disease caused by viral agents of hemorrhagic fever (60–
63). Studies in mice suggest that the protective efficacy of pas-
sive antibody action against Ebola virus (EBOV) is a result of
suppression of viral growth that allows development of immu-
nity (60). Hyperimmune goat serum generated by immuniza-
tion with live EBOV protected guinea pigs against lethal
challenge (64). Passive antibody therapy for EBOV infection
may be effective in humans, as suggested by lower death rates
in recipients of blood transfusions from convalescent patients
(57). Two caveats in the use of passive antibody therapy with
immune sera against hemorrhagic fevers that have emerged
from studies in animal models are the existence of disease-
enhancing antibodies (65) and the need for high-titer sera to
achieve protection (66). However, problems with deleterious
antibodies and insufficient activity could potentially be
avoided by the use of MAb cocktails composed only of protec-
tive antibodies with high specific activity. In this regard,
MAbs to EBOV have been developed that are protective in
mice even when administered 2 days after infection (67).
----------
Defense against filoviruses (ebola) used as biological weapons
www.sciencedirect.com...
"The filoviruses, Marburg and Ebola, are classified as Category A biowarfare agents by the Centers for Disease Control. Most known human infections
with these viruses have been fatal, and no vaccines or effective therapies are currently available. Filoviruses are highly infectious by the airborne
route in the laboratory"
------------
ebola can effectively be neutralized by anti body!
www.ncbi.nlm.nih.gov...
-----
edit on 21-8-2014 by Starbucks because: (no reason given)